Massarweh Nader N, Dickson Paxton V, Anaya Daniel A
VA HSR&D Center for Innovations in Quality, Effectiveness and Safety, Michael E DeBakey VA Medical Center, Houston, Texas; Michael E DeBakey Department of Surgery, Division of Surgical Oncology, Baylor College of Medicine, Houston, Texas.
J Surg Oncol. 2015 Apr;111(5):532-9. doi: 10.1002/jso.23851. Epub 2014 Dec 5.
Soft tissue sarcomas (STS) are a rare and heterogenous group of tumors that often represent a management challenge. The American Joint Committee on Cancer system is currently used to stage tumors and direct treatment. Limitations of the current STS staging system, future potential direction for pre-operative staging, as well as the benefit of predictive nomograms for filling current knowledge gaps are all discussed. J. Surg. Oncol. 2015 111:532-539. Published 2014. This article has been contributed to by US Government employees and their work is in the public domain in the USA.
软组织肉瘤(STS)是一类罕见且异质性的肿瘤,常常给治疗带来挑战。目前采用美国癌症联合委员会系统对肿瘤进行分期并指导治疗。本文讨论了当前STS分期系统的局限性、术前分期的未来潜在方向,以及预测列线图在填补当前知识空白方面的作用。《外科肿瘤学杂志》2015年第111卷:532 - 539页。2014年发表。本文由美国政府雇员撰写,其在美国属于公共领域作品。